RESUMEN
Research has recently demonstrated that larval zebrafish show similar molecular responses to nociception to those of adults. Our study explored whether unprotected larval zebrafish exhibited altered behaviour after exposure to noxious chemicals and screened a range of analgesic drugs to determine their efficacy to reduce these responses. This approach aimed to validate larval zebrafish as a reliable replacement for adults as well as providing a high-throughput means of analysing behavioural responses. Zebrafish at 5 days post-fertilization were exposed to known noxious stimuli: acetic acid (0.01%, 0.1% and 0.25%) and citric acid (0.1%, 1% and 5%). The behavioural response of each was recorded and analysed using novel tracking software that measures time spent active in 25 larvae at one time. Subsequently, the efficacy of aspirin, lidocaine, morphine and flunixin as analgesics after exposure to 0.1% acetic acid was tested. Larvae exposed to 0.1% and 0.25% acetic acid spent less time active, whereas those exposed to 0.01% acetic acid and 0.1-5% citric acid showed an increase in swimming activity. Administration of 2.5â mgâ l-1 aspirin, 5â mgâ l-1 lidocaine and 48â mgâ l-1 morphine prevented the behavioural changes induced by acetic acid. These results suggest that larvae respond to a noxious challenge in a similar way to adult zebrafish and other vertebrates and that the effect of nociception on activity can be ameliorated by using analgesics. Therefore, adopting larval zebrafish could represent a direct replacement of a protected adult fish with a non-protected form in pain- and nociception-related research.
Asunto(s)
Ácido Acético/farmacología , Analgésicos/farmacología , Conducta Animal/efectos de los fármacos , Ácido Cítrico/farmacología , Nocicepción/efectos de los fármacos , Noxas/farmacología , Pez Cebra/fisiología , Animales , Aspirina/farmacología , Clonixina/análogos & derivados , Clonixina/farmacología , Evaluación Preclínica de Medicamentos/métodos , Larva/efectos de los fármacos , Larva/fisiología , Lidocaína/farmacología , Morfina/farmacología , Estimulación Química , NataciónRESUMEN
Diagnosis of hydrocephalus symptoms and shunting system faults currently are based on clinical observation, monitoring of cranial growth, transfontanelle pressure, imaging techniques and, on occasion, studies of cerebrospinal fluid (CSF) dynamics. Up to date, the patient has to visit the hospital or meet consultant to diagnose the symptoms that occur due to rising of intracranial pressure or any shunt complications, which cause suffering for the patient and his family. This work presents the design and implementation of an expert system based on real-time patient feedback that aims to provide a suitable decision for hydrocephalus management and shunt diagnosis. Such decision would help in personalising the management as well as detecting and identifying of any shunt malfunctions without the need to contact or visit the hospital. In this paper, the development of patient feedback expert system is described. The outcome of such system would help satisfy the patient's needs regarding his/her shunt.
Asunto(s)
Diagnóstico por Computador/métodos , Sistemas Especialistas , Hidrocefalia/diagnóstico , Hidrocefalia/terapia , Programas Informáticos , Terapia Asistida por Computador/métodos , Interfaz Usuario-Computador , Biorretroalimentación Psicológica/métodos , HumanosRESUMEN
Hydrocephalus is a neurological disease that manifests itself in an elevated fluid pressure within the brain, and if left untreated, may be fatal. It is currently treated using shunt implants, which consist of a mechanical valve and tubes that regulate the pressure of cerebrospinal fluid (CSF) by draining excess fluid into the abdomen. Hydrocephalus shunting systems are no longer expected simply to regulate the intracranial pressure (ICP), but also to offer the option of regaining independence of the shunt. Additionally, they could offer personalised valve management which is one of the main limitations of current shunts. This paper describes the design of a multi-agent system for an intelligent and personalised CSF management system. Patient feedback and intracranial pressure readings will play important roles in the process of CSF regulation and weaning, introduces an element of personalisation to the treatment. The new shunting system would deliver both reactive and goal-driven solutions for the treatment, at the same time the intelligent part of the system will be monitoring how well the shunt is performing. These tasks can be achieved by implementing an agent approach in designing this system. Such system would help us to understand more about the dynamics of hydrocephalus.